Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macimorelin for Diagnosis of Adult Growth Hormone Deficiency
NCT00448747Phase 3Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Jun 2007
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of macimorelin in adult growth hormone deficiency (AGHD), sponsored by COSCIENS Biopharma Inc.. Started Jun 2007; status: completed.
02
Drugs
macimorelin
03
Conditions
adult growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on NCT00448747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448747.